|
|
|
|
LEADER |
01818nam a2200301 u 4500 |
001 |
EB001999833 |
003 |
EBX01000000000000001162734 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Brett, Kendra
|
245 |
0 |
0 |
|a Tuberculosis in people with compromised immunity
|h Elektronische Ressource
|b a review of guidelines
|c Kendra Brett, Camille Dulong, Melissa Severn
|
250 |
|
|
|a Version 1.0
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c March 11, 2020, 2020
|
300 |
|
|
|a 1 PDF file (46 pages)
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Evidence-Based Medicine
|
653 |
|
|
|a Tuberculosis
|
653 |
|
|
|a Guidelines as Topic
|
700 |
1 |
|
|a Dulong, Camille
|e [author]
|
700 |
1 |
|
|a Severn, Melissa
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK562936
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The purpose of this report is to review and critically appraise the evidence-based guidelines regarding the prevention, identification, and treatment of TB for patients with compromised immunity. This report is part of series of evidence reviews on TB guidelines and can serve as a guidance document to identify which guidelines include recommendations for TB in patients with compromised immunity and the strength of the guidelines. This report covers recommendations regarding the prevention, identification, and treatment of TB in people with HIV or other conditions that compromise the immune system
|